Development of a Carrier-Free Dry Powder Ofloxacin Formulation With Enhanced Aerosolization Properties
- 1 September 2020
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 109 (9) , 2787-2797
Abstract
No abstract availableKeywords
Funding Information
- Consejo Nacional de Investigaciones Científicas y Técnicas
- Fondo para la Investigación Científica y Tecnológica
- Universidad Nacional del Sur
This publication has 47 references indexed in Scilit:
- Advances in Mucoadhesion and Mucoadhesive PolymersMacromolecular Bioscience, 2010
- Characterization of the Solubility and Solid-State Properties of Saccharin Salts of FluoroquinolonesJournal of Pharmaceutical Sciences, 2009
- Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosisJournal of Controlled Release, 2008
- In Vitro / In Vivo Comparisons in Pulmonary Drug DeliveryJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2008
- Pharmaceutical Particle Engineering via Spray DryingPharmaceutical Research, 2007
- Quenching of Ofloxacin and Flumequine Fluorescence by Divalent Transition Metal CationsBulletin of the Korean Chemical Society, 2006
- Release behavior of microspheres from cross-linked N-methylated chitosan encapsulated ofloxacinCarbohydrate Polymers, 2006
- Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosisInternational Journal of Antimicrobial Agents, 2005
- Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skinJournal of the European Academy of Dermatology and Venereology, 2005
- Aqueous solubilities of some variously substituted quinolone antimicrobialsInternational Journal of Pharmaceutics, 1990